Retiro De Equipo (Recall) de Device Recall BD ReticCount" Reticulocyte Reagent System

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por Becton, Dickinson and Company, BD Biosciences.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    73597
  • Clase de Riesgo del Evento
    Class 3
  • Número del evento
    Z-1390-2016
  • Fecha de inicio del evento
    2016-03-18
  • Estado del evento
    Terminated
  • País del evento
  • Fecha de finalización del evento
    2016-12-02
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Counter, cell, automated (particle counter) - Product Code GKL
  • Causa
    The carton label for one lot of bd retic-count reticulocyte reagent system had the incorrect storage conditions. the labels on the reagent as well as the instructions for use are correct.
  • Acción
    BD Biosciences sent an Urgent Product Recall letter on March 18, 2016, to all affected customers by certified mail. The letter identified the product the problem and the action needed to be taken by the customer. Customer Actions: 1. Examine your data files obtained using reagents from the affected lots for low performance. 2. Discard all remaining stock of BD Retic-Counter reticulocyte reagent system, Catalog Number 349204, lot number 5175559, and request replacement product. BD will replace product at no cost. 3. As a requirement of our Regulatory Tracking Process, we request that you complete the enclosed Tracking/Verification form , even if you no longer have the affected reagents listed in your inventory. Please return the Tracking/Verification form to BD Biosciences, per the instructions (mail, fax, or email). If you require further assistance, please contact BD Customer Support at 877.232.8995 (prompt 3, 3) in the United States. For customers outside the US, contact your local BD Biosciences representative or distributor.

Device

  • Modelo / Serial
    Product number 349214, Lot number 5175559, Expiry 5/31/16.
  • Clasificación del producto
  • Clase de dispositivo
    2
  • ¿Implante?
    No
  • Distribución
    Worldwide Distribution - US Distribution to the states of : CT, MN, FL, NY, CA, MA, DC, UT, VA and IN., and to the countries of : Belgium, Brazil, Canada, China, India, Japan, Korea, Singapore and Taiwan.
  • Descripción del producto
    BD-Retic-Count Reticulocyte Reagent System; || Hematology: Used for in vitro diagnostics
  • Manufacturer

Manufacturer

  • Dirección del fabricante
    Becton, Dickinson and Company, BD Biosciences, 2350 Qume Dr, San Jose CA 95131-1812
  • Empresa matriz del fabricante (2017)
  • Source
    USFDA